中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo

文献类型:期刊论文

作者Jiang, Zhenqi; Wang, Yinjie; Sun, Li; Yuan, Bo; Tian, Yuchen; Xiang, Lingchao; Li, Yanying; Li, Yong; Li, Juan; Wu, Aiguo
刊名BIOMATERIALS
出版日期2019
卷号197页码:41-50
关键词METAL-ORGANIC FRAMEWORKS ROOM-TEMPERATURE SYNTHESIS NEUROPEPTIDE-Y ANALOGS ONE-POT SYNTHESIS DRUG-RESISTANCE ANTICANCER DRUG DELIVERY NANOPARTICLES MEMBRANE NANOCRYSTALS
DOI10.1016/j.biomaterials.2019.01.001
英文摘要Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo
源URL[http://ir.nimte.ac.cn/handle/174433/18515]  
专题2019专题
作者单位1.Li, J
2.Wu, AG (reprint author), Chinese Acad Sci, CAS Key Lab Magnet Mat & Devices, Key Lab Addit Mfg Mat Zhejiang Prov, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Zhejiang, Peoples R China.
3.Wu, AG (reprint author), Chinese Acad Sci, Div Funct Mat & Nanodevices, Ningbo Inst Mat Technol & Engn, Ningbo 315201, Zhejiang, Peoples R China.
推荐引用方式
GB/T 7714
Jiang, Zhenqi,Wang, Yinjie,Sun, Li,et al. Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo[J]. BIOMATERIALS,2019,197:41-50.
APA Jiang, Zhenqi.,Wang, Yinjie.,Sun, Li.,Yuan, Bo.,Tian, Yuchen.,...&Wu, Aiguo.(2019).Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo.BIOMATERIALS,197,41-50.
MLA Jiang, Zhenqi,et al."Dual ATP and pH responsive ZIF-90 nanosystem with favorable biocompatibility and facile post-modification improves therapeutic outcomes of triple negative breast cancer in vivo".BIOMATERIALS 197(2019):41-50.

入库方式: OAI收割

来源:宁波材料技术与工程研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。